At the Decision Tree, Thomas Goetz blogs that he is "fearful" that with all the interest by Congress in personal genetic testing that "the FDA will feel obligated to regulate and shut us off from what is rightfully ours." Goetz adds that "this isn't a drug, and this isn't a device — it's information about ourselves" and that it provides consumers with the ability "to take control of their health."